News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsTraining Academy
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEvents
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Anaisys Rueda, MSN, APRN-BC

Advertisement

Articles by Anaisys Rueda, MSN, APRN-BC

young adult with cancer

Challenges Faced by Adolescent and Young Adult Patients With Cancer

ByAnaisys Rueda, MSN, APRN-BC,Jessica MacIntyre, DNP, MBA, NP-C, APRN, AOCNP,Amber Thomassen, APRN-BC
December 16th 2022

Adolescents and young adults who have cancer also have a negative body image, financial toxicity, and concerns about family planning.

Advertisement

Latest Updated Articles

  • young adult with cancer
    Challenges Faced by Adolescent and Young Adult Patients With Cancer

    Published: December 16th 2022 | Updated:



Advertisement
Advertisement

Trending on Oncology Nursing News

1

Sacituzumab Govitecan/Pembro Maintains QOL, Physical Functioning in mTNBC

2

T-DXd Plus Pertuzumab Sustains PFS Benefit Across HER2+ BC Subgroups

3

VCN-01 Plus SOC Improves Survival, Is Safe in Metastatic PDAC

4

Buparlisib/Chemo Combo Misses OS Mark in PD-1–Treated Recurrent HNC

5

Operationalizing SubQ Immune Checkpoint Inhibitors in Clinical Practice

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us